[Federal Register Volume 71, Number 32 (Thursday, February 16, 2006)]
[Notices]
[Page 8304]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E6-2234]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Office of the Secretary


Findings of Scientific Misconduct

AGENCY: Office of the Secretary, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that the Office of Research Integrity 
(ORI), the Assistant Secretary for Health, and another Federal agency 
have taken final action in the following case:
    Amy Beth Goldring, University of California at Los Angeles: Based 
on an investigation conducted by the University of California at Los 
Angeles (UCLA) and additional analysis conducted by the Office of 
Research Integrity (ORI) in its oversight review, ORI found that Ms. 
Goldring, former graduate student, Department of Psychology, UCLA, 
engaged in scientific misconduct by falsifying or fabricating data and 
statistical results for up to nine pilot studies on the impact of 
vulnerability on decision-making from Fall 2000 to Winter 2002 as a 
basis for her doctoral thesis research. The falsified or fabricated 
data was included in a manuscript submitted to Psychological Science, 
in National Institutes of Mental Health (NIMH), National Institutes of 
Health (NIH), grant application 1 R01 MH65238-01A1, and in NIMH, NIH, 
pre-doctoral training grant T32 MH15750.
    Ms. Goldring has been debarred by another agency with joint 
jurisdiction for a period of three (3) years, beginning on May 13, 
2005, and ending on May 13, 2008. On December 16, 2005, Ms. Goldring 
received a detailed explanation of ORI's proposed finding and was given 
thirty (30) days to contest the finding and the proposed administrative 
action. The thirty-day period has elapsed and ORI has not received a 
response. Accordingly, the following administrative action has been 
implemented for a period of three (3) years, beginning on January 18, 
2006:
    (1) Ms. Goldring is prohibited from serving in any advisory 
capacity to PHS, including but not limited to service on any PHS 
advisory committee, board, and/or peer review committee, or as a 
consultant.

FOR FURTHER INFORMATION CONTACT: Director, Division of Research 
Investigations, Office of Research Integrity, 1101 Wootton Parkway, 
Suite 750, Rockville, MD 20852, (240) 453-8800.

Chris B. Pascal,
Director, Office of Research Integrity.
 [FR Doc. E6-2234 Filed 2-15-06; 8:45 am]
BILLING CODE 4160-17-P